Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1997-8-27
pubmed:abstractText
The thiadiazinone derivative [+]-EMD 60263 ((+)-5-(l-(alpha-ethylimino-3,4-dimethoxybenzyl)-1,2,3,4-tetrah ydroquinoline -6-yl)-6-methyl-3,6-dihydro-2H-1,3,4 -thiadiazine-2-on) is a Ca(2+)-sensitizing agent with only minor phosphodiesterase inhibitory activity. Our aim was to characterize the inotropic and electrophysiological effects of [+]-EMD 60263 and its enantiomer [-]-EMD 60264 in several cardiac muscle preparations. The Ca(2+)-sensitizing activity resided in the [+]-enantiomer only. [+]-EMD 60263 (3 microM) shifted the EC50 of Ca2+ for contractile activation of skinned fibers of pig heart from 2.41 microM to 0.73 microM, whereas [-]-EMD 60264 (30 microM) was ineffective. In Langendorff-perfused guinea pig hearts, [+]-EMD 60263 and [-]-EMD 60264 induced concentration-dependent positive and negative inotropic effects, respectively; both enantiomers reduced spontaneous heart rate but did not influence perfusion pressure. The maximum increase in force of human atrial trabeculae was 35% of pre-drug control with [+]-EMD 60263 in comparison to 113% with forskolin. In guinea-pig papillary muscles, [+]-EMD 60263 and [-]-EMD 60264 had opposite inotropic responses, however, both agents similarly prolonged action potential duration. Both enantiomers concentration-dependently blocked the rapidly activating component IKr of the delayed rectifier in guinea-pig myocytes. The block saturated at potentials positive to +30 mV, closely resembling the effects of the antiarrhythmic agent E-4031 which had been originally used to define IKr.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0028-1298
pubmed:author
pubmed:issnType
Print
pubmed:volume
355
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
733-42
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:9205958-3',5'-Cyclic-AMP Phosphodiesterases, pubmed-meshheading:9205958-Action Potentials, pubmed-meshheading:9205958-Animals, pubmed-meshheading:9205958-Atrial Function, pubmed-meshheading:9205958-Calcium, pubmed-meshheading:9205958-Cyclic Nucleotide Phosphodiesterases, Type 3, pubmed-meshheading:9205958-Electric Stimulation, pubmed-meshheading:9205958-Guinea Pigs, pubmed-meshheading:9205958-Heart Rate, pubmed-meshheading:9205958-Heart Ventricles, pubmed-meshheading:9205958-Humans, pubmed-meshheading:9205958-Male, pubmed-meshheading:9205958-Membrane Potentials, pubmed-meshheading:9205958-Myocardial Contraction, pubmed-meshheading:9205958-Papillary Muscles, pubmed-meshheading:9205958-Patch-Clamp Techniques, pubmed-meshheading:9205958-Stereoisomerism, pubmed-meshheading:9205958-Swine, pubmed-meshheading:9205958-Thiadiazines, pubmed-meshheading:9205958-Ventricular Function
pubmed:year
1997
pubmed:articleTitle
Stereoselectivity of actions of the calcium sensitizer [+]-EMD 60263 and its enantiomer [-]-EMD 60264.
pubmed:affiliation
Institut für Pharmakologie, Universitätsklinikum Essen, Germany.
pubmed:publicationType
Journal Article, In Vitro